INTERACTION BETWEEN RISTOCETIN AND RISTOCETIN COFACTOR (RCOF)

被引：22

作者：

FLOYD, M

BURNS, W

GREEN, D

机构：

[1] NORTHWESTERN UNIV,SCH MED,DEPT MED,NEPHROL HYPERTENS,CHICAGO,IL 60611

[2] NORTHWESTERN UNIV,SCH MED,DEPT MED,HEMATOL SECT,CHICAGO,IL 60611

来源：

THROMBOSIS RESEARCH | 1977年 / 10卷 / 06期

关键词：

D O I：

10.1016/0049-3848(77)90141-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：841 / 850

页数：10

共 21 条

[1]

DENSON KWE, 1966, TREATMENT HAEMOPHILI, P350

[2]

GOH ATW, IN PRESS

[3]

GREEN D, 1976, J LAB CLIN MED, V87, P976

[4]

GREEN D, 1974, CLIN RES, V22, P638

[5] RISTOCETIN - MEANS OF DIFFERENTIATING VONKARMAN WILLEBRANDS DISEASE INTO 2 GROUPS [J].

HOWARD, MA ;

SAWERS, RJ ;

FIRKIN, BG .

BLOOD, 1973, 41 (05) :687-690

[6]

HOWARD MA, 1971, THROMB DIATH HAEMOST, V26, P362

[7] WILLEBRAND FACTOR AND RISTOCETIN .1. MECHANISM OF RISTOCETIN-INDUCED PLATELET-AGGREGATION [J].

JENKINS, CSP ;

MEYER, D ;

DREYFUS, MD ;

LARRIEU, MJ .

BRITISH JOURNAL OF HAEMATOLOGY, 1974, 28 (04) :561-578

[8]

LOWRY OH, 1951, J BIOL CHEM, V193, P265

[9] WILLEBRAND FACTOR AND RISTOCETIN .2. RELATIONSHIP BETWEEN WILLEBRAND FACTOR, WILLEBRAND ANTIGEN AND FACTOR-VIII ACTIVITY [J].

MEYER, D ;

JENKINS, CSP ;

DREYFUS, MD ;

FRESSINAUD, E ;

LARRIEU, MJ .

BRITISH JOURNAL OF HAEMATOLOGY, 1974, 28 (04) :579-599

[10]

MICHAELI D, 1976, PROGR HEMOSTASIS THR, P52

← 1 2 3 →